Selenium and Thyroid Disease: From Pathophysiology to Treatment

被引:167
作者
Ventura, Mara [1 ]
Melo, Miguel [1 ,2 ]
Carrilho, Francisco [1 ]
机构
[1] Ctr Hosp & Univ Coimbra, Dept Endocrinol Diabet & Metab, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
关键词
AUTOIMMUNE-THYROIDITIS; SERUM SELENIUM; SELENOPROTEIN-P; GRAVES-DISEASE; SUPPLEMENTATION; ASSOCIATION; POPULATION; CANCER; VOLUME; WOMEN;
D O I
10.1155/2017/1297658
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction. Selenium is a micronutrient embedded in several proteins. In adults, the thyroid is the organ with the highest amount of selenium per gram of tissue. Selenium levels in the body depend on the characteristics of the population and its diet, geographic area, and soil composition. In the thyroid, selenium is required for the antioxidant function and for the metabolism of thyroid hormones. Methods. We performed a review of the literature on selenium's role in thyroid function using PubMed/MEDLINE. Results. Regarding thyroid pathology, selenium intake has been particularly associated with autoimmune disorders. The literature suggests that selenium supplementation of patients with autoimmune thyroiditis is associated with a reduction in antithyroperoxidase antibody levels, improved thyroid ultrasound features, and improved quality of life. Selenium supplementation in Graves' orbitopathy is associated with an improvement of quality of life and eye involvement, as well as delayed progression of ocular disorders. The organic form of selenium seems to be the preferable formulation for supplementation or treatment. Conclusion. Maintaining a physiological concentration of selenium is a prerequisite to prevent thyroid disease and preserve overall health. Supplementation with the organic form is more effective, and patients with autoimmune thyroiditis seem to have benefits in immunological mechanisms. Selenium supplementation proved to be clinically beneficial in patients with mild to moderate Graves' orbitopathy.
引用
收藏
页数:9
相关论文
共 53 条
[1]
[Anonymous], 2001, DIETARY REFERENCE IN, DOI DOI 10.1016/S0899-9007(00)00596-7
[2]
ATSDR, 2003, TOX PROF SEL
[3]
MECHANISMS OF DISEASE Graves' Ophthalmopathy [J].
Bahn, Rebecca S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :726-738
[4]
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy [J].
Bartalena, Luigi ;
Baldeschi, Lelio ;
Boboridis, Kostas ;
Eckstein, Anja ;
Kahaly, George J. ;
Marcocci, Claudio ;
Perros, Petros ;
Salvi, Mario ;
Wiersinga, Wilmar M. .
EUROPEAN THYROID JOURNAL, 2016, 5 (01) :9-26
[5]
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults [J].
Bleys, Joachim ;
Navas-Acien, Ana ;
Guallar, Eliseo .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (04) :404-410
[6]
Session 2: Micronutrients and the immune system Role of selenium-containing proteins in T-cell and macrophage function [J].
Carlson, Bradley A. ;
Yoo, Min-Hyuk ;
Shrimali, Rajeev K. ;
Irons, Robert ;
Gladyshev, Vadim N. ;
Hatfield, Dolph L. ;
Park, Jin Mo .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (03) :300-310
[7]
Association of selenium with thyroid volume and echostructure in 35-to 60-year-old French adults [J].
Derumeaux, H ;
Valeix, P ;
Castetbon, K ;
Bensimon, M ;
Boutron-Ruault, MC ;
Arnaud, J ;
Hercberg, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (03) :309-315
[8]
Selenium supplementation in thyroid associated ophthalmopathy: an update [J].
Dharmasena, Aruna .
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (02) :365-375
[9]
SELENIUM IN BLOOD AND HUMAN TISSUES [J].
DICKSON, RC ;
TOMLINSON, RH .
CLINICA CHIMICA ACTA, 1967, 16 (02) :311-+
[10]
Selenium and the thyroid gland: more good news for clinicians [J].
Drutel, Anne ;
Archambeaud, Francoise ;
Caron, Philippe .
CLINICAL ENDOCRINOLOGY, 2013, 78 (02) :155-164